[go: up one dir, main page]

AU617573C - Sustained release pharmaceutical composition - Google Patents

Sustained release pharmaceutical composition

Info

Publication number
AU617573C
AU617573C AU47732/90A AU4773290A AU617573C AU 617573 C AU617573 C AU 617573C AU 47732/90 A AU47732/90 A AU 47732/90A AU 4773290 A AU4773290 A AU 4773290A AU 617573 C AU617573 C AU 617573C
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
sustained release
release pharmaceutical
sustained
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU47732/90A
Other versions
AU617573B2 (en
AU4773290A (en
Inventor
Mark Christopher Fisher
Angelo Mario Morella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma International Pty Ltd
Original Assignee
Mayne Pharma International Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayne Pharma International Pty Ltd filed Critical Mayne Pharma International Pty Ltd
Publication of AU4773290A publication Critical patent/AU4773290A/en
Publication of AU617573B2 publication Critical patent/AU617573B2/en
Application granted granted Critical
Publication of AU617573C publication Critical patent/AU617573C/en
Assigned to MAYNE PHARMA INTERNATIONAL PTY LTD reassignment MAYNE PHARMA INTERNATIONAL PTY LTD Request to Amend Deed and Register Assignors: F.H. FAULDING & CO. LIMITED
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU47732/90A 1989-01-06 1990-01-05 Sustained release pharmaceutical composition Expired AU617573C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ2192 1989-01-06
AUPJ219289 1989-01-06

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU41654/93A Addition AU668174C (en) 1993-06-30 1993-06-30 Sustained release pharmaceutical composition

Publications (3)

Publication Number Publication Date
AU4773290A AU4773290A (en) 1990-07-12
AU617573B2 AU617573B2 (en) 1991-11-28
AU617573C true AU617573C (en) 1998-03-05

Family

ID=

Similar Documents

Publication Publication Date Title
AU622526B2 (en) Sustained release pharmaceutical preparation
AU2707788A (en) Sustained release pharmaceutical composition
GB2230185B (en) Sustained release pharmaceutical compositions
AU639947B2 (en) Sustained release elements
AU6893287A (en) Sustained release pharmaceutical preparation
AU2746992A (en) Controlled release pharmaceutical compositions
AU4341789A (en) Pharmaceutical formulations
AU4148989A (en) Pharmaceutical compositions
AU3674489A (en) Pharmaceutical compositions
AU5541290A (en) Pharmaceutical compositions
AU5943990A (en) Sustained release pharmaceutical compositions
AU5316890A (en) Composition
GB2232891B (en) Pharmaceutical composition
AU6012990A (en) Pharmaceutical formulation
AU5276690A (en) Pharmaceutical compositions
AU2876889A (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
AU5680990A (en) Composition
AU3298589A (en) New pharmaceutical composition
AU617573C (en) Sustained release pharmaceutical composition
AU7135091A (en) Pharmaceutical composition
AU663388B2 (en) Sustained release formulations
AU668174C (en) Sustained release pharmaceutical composition
AU4819490A (en) Pharmaceutical compositions
AU627968B2 (en) Frying-fat composition
AU4165493A (en) Sustained release pharmaceutical composition